Who
Patrick D. Kirwin
Director
Company insider
Files Form 4 as: Director, ProMIS Neurosciences.
In numbers
- Trades disclosed
- 15
- Buys
- 6
- Sells
- 0
- Bought
- $146K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 17 Aug 2022
- Last trade
- 22 Apr 2026
- Last filed
- 23 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Apr 2026filed 23 Apr 2026 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $45K4,000 at $11.33 | filing |
| 22 Apr 2026filed 23 Apr 2026 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $45K4,000 at $11.33 | filing |
| 3 Feb 2026filed 5 Feb 2026 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Code A | $37K3,050 at $12.13 | filing |
| 3 Feb 2026filed 5 Feb 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,050 | filing |
| 3 Feb 2026filed 5 Feb 2026 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,050 | filing |
| 3 Feb 2026filed 5 Feb 2026 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Code A | $37K3,050 at $12.13 | filing |
| 12 Jun 2025filed 16 Jun 2025 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 3 Oct 2024filed 7 Oct 2024 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 14 Aug 2024filed 16 Aug 2024 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $13K10,000 at $1.25 | filing |
| 23 Aug 2023filed 25 Aug 2023 | PMN ProMIS Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,000 | filing |
| 23 Aug 2023filed 25 Aug 2023 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Code A | —11,000 | filing |
| 15 Dec 2022filed 15 Dec 2022 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $9,0202,000 at $4.51 | filing |
| 13 Dec 2022filed 15 Dec 2022 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $4,8701,000 at $4.87 | filing |
| 9 Dec 2022filed 13 Dec 2022 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $4,9801,000 at $4.98 | filing |
| 17 Aug 2022filed 18 Aug 2022 | PMN ProMIS NeurosciencesBiotechnology | SEC FORM 4 Bought | $24K4,000 at $5.92 | filing |
News
No headline names them, or the companies they trade most, lately.